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Pili  are  polymeric  filaments  extending  from  the  cell  envelope  of Neisseria 
gonorrhoeae  that promote infectivity by binding to epithelial cell surfaces (1-6). 
Since antisera  directed at pili  may block mucosal adherence by gonococci and 
therefore their  capacity to colonize urogenital  epithelium,  pili  have been pro- 
posed as  vaccine  constituents  for the  prevention  of gonorrhea  (1).  However, 
gonococcal pili are antigenically heterogeneous and the protection conferred by 
a  vaccine  composed of undenatured  pilus  filaments  from  a  single  gonococcal 
strain appears to be strain specific. Yet, antisera against pili from one strain can 
cross-react weakly with pili from other strains,  implying that a  common deter- 
minant could exist (1). Characterization  of a common determinant might lead to 
the development of a suitable immunogen for the prevention of gonorrhea. 
To investigate  the structural  basis of these serologic properties,  we recently 
have determined  the complete amino acid sequence of pilin  isolated from the 
transparent  colonial  variant  (Tr) 1 of strain  MS11  and  the  partial  sequence of 
RI0 (Tr) pilin  (7).  The comparison  of these two sequences and  the previously 
reported  serological  properties  of antisera  directed  against  the  two  principal 
cyanogen  bromide-generated  fragments  of pilin  (CNBr-2,  residues  9-92  and 
CNBr-3, residues 93-159)  have enabled us to construct an antigenic  model of 
the protein  (8).  The  immunodominant,  antigenicaily  variable region  is  within 
CNBr-3, while CNBr-2 contains a conserved receptor binding region and possibly 
an immunorecessive epitope common to all gonococcal pilin (8). 
In this study, peptides corresponding to both variable and constant regions of 
MS11  pilin  were  synthesized  in  order  to  (a)  more  precisely  determine  the 
antigenic structure of pilin, (b) understand the molecular details of the antigenic 
variation in the protein, and (c) identify regions of the protein that might elicit 
antisera  that  would inhibit  the  binding  of all  gonococcal strains  to  eucaryotic 
cells.  Each  peptide  was  tested  for  its  ability  to  be  bound  by polyclonal  sera 
This work was supported, in part, by a grant from the Veterans Administration and by a grant from 
the Institut Merieux. G. K. S. is a Fellow of the John A. Hartford Foundation. Correspondence 
should be addressed to him at the Department of Medicine, Division of Infectious Diseases, Stanford 
University Medical School, Stanford, CA 94305. 
1Abbreviations used in this paper:  BSA, bovine serum albumin; CNBr-2, cyanogen bromide- 
generated fragment of pilin, residues 9-92; CNBr-3, CNBr-generated fragment ofpilin,  residues 
95-159; DCC, dicyclohexylcarbodiimide;  SMCC, succinimidyl 4-(N-maleimido-methyl)cyclohexane- 
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directed  against  pili  isolated  from  homologous and  heterologous  gonococcal 
strains.  In addition, antisera directed against CNBr-2 and CNBr-3  were tested 
for their ability to bind the peptides.  An antigenic determinant common to all 
strains of pili and two separate  strain-specific epitopes  were  defined.  We also 
have demonstrated that antisera against CNBr-2 recognizes a different common 
determinant than that seen by sera against the intact pilus filaments. 
Materials and Methods 
Purification of Pili and the Generation of Cyanogen Bromide Fragments.  Pili purification 
and the generation and isolation of the cyanogen bromide-generated fragments, CNBr- 
2 and CNBr-3, from MS1 l(Tr) and R10(Tr) strains ofN. gonorrhoeae were performed as 
described previously (7). 
Specific Anti-Pili Antisera.  Antisera against undenatured pili from MS11 (Tr), R10(Tr), 
and against their two major cyanogen bromide-generated fragments (CNBr-2 and CNBr- 
3)  were prepared  in  female New  Zealand White rabbits.  50  #g of each protein  was 
emulsified in 1 ml of  phosphate-buffered saline with an equal volume of  complete Freund's 
adjuvant and administered by multiple subcutaneous injections.  Booster injections in 
Freund's incomplete adjuvant were administered 6 wk later. 10 d thereafter, the animals 
were bled by cardiac puncture and the sera were filter sterilized and stored at 4°C. 
Selection of the Peptides Synthesized.  Peptides believed to contain strain-specific  epitopes 
were chosen according to differences in  sequence between MS11  and  R10 pilin.  All 
known sequence differences between these two proteins occur between residues 93 and 
the carboxyi terminus, residue  159  (7,  8).  Particular importance was given to regions 
where amino acid substitutions significantly affected either the charge, the hydrophobic- 
ity/hydrophilicity,  or the predicted secoq,dary structure of the region. Regions of sequence 
homology between residues 8 and 92 were synthesized in an attempt to define a common 
epitope. We avoided regions that were very hydrophobic, but did not simply choose areas 
of great hydrophilicity. The association of the hydrophilicity of a region with antigenicity 
neglects the importance of hydrophobic interactions when an antibody binds an antigen 
(9). Consequently, regions that had both hydrophobic and hydrophilic character were 
preferred. 
The possible  conformations that the peptide can adopt when conjugated to a carrier 
protein also were considered. Only if a peptide adopts the identical secondary structure 
that it has in the intact protein will it both bind sera generated against the intact protein 
and elicit antibodies that cross-react with that protein. Of the three common secondary 
structures present in  proteins,  B-pleated  sheets,  a-helices, and reverse or B-turns,  we 
believe reverse turns have the highest probability of being present in an isolated oligopep- 
tide <15  residues in length. Therefore, a  peptide containing a  region with high turn 
probability will be more likely to be identical to the corresponding region in the intact 
protein than regions predicted to be sheets or helices. 
The B-turns were emphasized further by conjugating the peptide in an orientation that 
resulted in the B-turn being distal from the linkage to the carrier protein. 
Synthesis and Characterization of Peptides.  Peptides were synthesized by solid phase 
techniques  (10)  on  a  Beckman  model  990B  peptide  synthesizer  using  commercially 
available amino acid polystyrene resins and t-Boc-protected amino acids (Peninsula Lab- 
oratories, Belmont, CA), with the following side chain protecting groups: O-benzyl esters 
for Asp,  Giu, Thr, and Ser; tosyl for Arg and His; para-methoxybenzyl for Cys, ortho- 
chlorobenzyloxycarbonyl for Lys, and  2,6-dichlorobenzyl for Tyr. All  couplings were 
performed using a  2.5 molar excess of t-Boc amino acid and dicyclohexylcarbodiimide 
(DCC) over the number of milliequivalents of amino acid on the resin. In the case of Asn 
and Gin, a 2.5 molar excess of the amino acid, DCC, and N-hydroxy triazole was used. 
All couplings were >99%  complete, as determined by the reaction of the resin with 
ninhydrin (11). The peptides were deprotected and removed from the resin simultaneously 
by treatment with anhydrous hydrogen fluoride in  the presence  of anisole, dimethyl 
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by extraction with ether and isolated from the resin by extraction with 5% acetic acid and 
subsequent  lyophilization. The  purity of the  crude product was  determined  by high 
pressure liquid chromatography on a  C-18  reverse phase  column (Merck,  Darmstadt, 
Germany) and by amino acid analysis.  The peptides used in these experiments were not 
further purified since they all contained >90% of the desired product. 
Conjugation  of the Peptides to Carrier Proteins.  The peptides were conjugated to bovine 
serum albumin (BSA) using succinimidyl 4-(N-maleimido-methyl)cyclohexane-l-carboxy- 
late (SMCC) (Pierce, Rockford, I L) as described (12). Briefly, 10 mg of the carrier protein 
were dissolved in 2 ml phosphate-buffered saline, pH 7.4, and combined with 5 mg of 
crosslinker dissolved in 500 ul of dimethylformamide. After an hour, the conjugate was 
separated  from  unreacted  crosslinker by  gel  filtration  on  a  G-25  column  in  0.1  M 
phosphate, pH 6.0. The peptide to be conjugated was dissolved in 0.1  M borate, pH 9.1 
and reduced with  NaBH4 (100 t~l of 0.1  M stock). After 5  min the pH  of the borate 
solution was lowered to 1 with 1 M HC1, to remove the excess NaBH4, and then raised to 
pH  6  with  1  M  NaOH  and  combined  with  the  carrier-crosslinker conjugate.  After 
incubating for an additional hour the carrier-peptide conjugate was desalted on a G-25 
column in 0.1  M NH4HCO3. The degree of conjugation was quantitated by comparing 
the amino acid composition of the  carrier protein before and after reaction with  the 
peptide. The conjugates used in this study all contained between 15 and 25 peptides per 
molecule of BSA. 
Determination  of the Cross-reactivity of Sera Against Intact Pili and CNBr-2 and CNBr-3 of 
Pilin.  A two-step competitive ELISA was used to determine the cross-reactivity of sera 
directed against MS11  and R10 pili and their cyanogen bromide-generated fragments, 
CNBr-2  and  CNBr-3  (13).  Briefly, each  antisera  was  diluted  to  a  concentration that 
resulted in  60%  maximal binding to the antigen on a  solid phase.  The sera (100 #1) 
containing increasing concentrations of either MS11  or R10  pili  were added to wells 
precoated with 0.1  #g of either MS 11 or R 10 pili. The plates were incubated for 3 h at 
37 ° C, washed, treated with alkaline phosphatase-conjugated goat anti-rabbit IgG (Cappel, 
West Chester, PA), washed, treated with p-nitrophenyl phosphate (Sigma, St. Louis, MO), 
and read at 405 nm. 
Binding of Polyclonal  Sera to Peptide-Protein  Conjugates.  Rabbit polyclonal antibodies 
against either whole pili or cyanogen bromide-generated fragments of pilin, CNBr-2 and 
CNBr-3, were assayed for their ability to bind peptide-BSA conjugates by using solid 
phase binding assays. Briefly, 96-well plates were coated with  10 ~g of the peptide-BSA 
conjugate, washed, treated with serially diluted antisera, washed, and treated either with 
125I protein A (Amersham, Arlington Heights, IL) or a goat anti-rabbit alkaline phospha- 
tase conjugate (Cappel, West Chester, PA) followed by p-nitrophenyl phosphate (Sigma, 
St.  Louis, MO). The radioactive wells were cut from the plate and counted, while the 
wells containing the antibody-enzyme conjugates were read at 405 nm. 
Absorption of Antisera with Peptide-Carrier-Sepharose Conjugates.  The peptide-BSA con- 
jugates were reacted with cyanogen bromide-activated Sepharose (Pharmacia, Piscataway, 
NJ) as described (14). Anti-R10 and anti-MS11 pilus sera (1  ml) were absorbed with 100 
t~l of either peptide 121-134-BSA or 135-151-BSA sepharose for 2 h at room temperature. 
The mixture was spun and the absorbed sera was separated and assayed for the complete 
removal of the specific anti-peptide antibody by a solid phase binding assay. 
Results 
Shared Antigenicity  of RlO and MSll  Pili.  Previous studies by Brinton et al. 
(1) demonstrated that antisera against gonococcal pili are directed principally at 
strain-specific epitopes. However, the sera also contain antibodies that cross-react 
with pili of other strains. This cross-reactivity could be due to either differential 
binding at strain-specific epitopes as a  result of amino acid sequence variations 
or due  to the  presence of a  weakly  immunogenic determinant  common  to all 
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initially  were  tested  using a  two-step  inhibition  solid  phase  binding  assay  to 
determine their specificity (1:3). As seen in Fig.  1,A and B, the anti-whole pili 
sera is quite strain specific. The shared antigenicity detected by both sera is only 
~5%. Whether the cross-reactivity of the sera is due to epitopes common to all 
pill  or  due  to  differential  binding  at  strain-specific  determinants  was  partly 
answered by examining the antigenic relatedness detected by the sera against 
two cyanogen bromide-generated  fragments  of pilin,  CNBr-2,  residues  8-92 
and CNBr-3,  residues 93-159.  A  marked difference is apparent in the shared 
antigenicity detected by the sera directed against CNBr-2 (Fig.  1, C and D) from 
that against CNBr-3 (Fig.  1, E and F). In the former case the cross-reactivity was 
almost complete, whereas antisera  against the carboxyl terminal fragment dis- 
played high strain specificity. These experiments indicate that a  weakly immu- 
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FIGURE  1.  The specificity of antisera generated against either intact MS11  pill, intact R10 
pill, or each of their principal cyanogen bromide-generated fragments, CNBr-2 (residues 9- 
92) and CNBr-3 (residues 93-159). Antisera against intact MSI 1 pill (A), MS11 (CNBr-2 (C), 
and MS11 CNBr-3 (E) were assayed in a two-step competitive ELISA for their ability to bind 
wells coated with MSI 1 (Tr) pill in the presence of increasing amounts of either soluble R10 
or MS11  pill (abscissa).  Similarly, antisera against intact R10 pill (B), R10 CNBr-2 (D), and 
R10 CNBr-3 (F) were tested for their ability to bind wells coated with R10 (Tr) pill in the 
presence of increasing concentrations of soluble MS 11 and R 10 pill (abscissa). 212  ANTIGENIC STRUCTURE  OF GONOCOCCAL PILl 
nogenic, common epitope(s)  exists between residues  9-92  and that the strain- 
specific, immunodominant determinant(s) is located between residues 93-159. 
The precise location of each of these epitopes was determined by examining the 
antigenicity of synthetic peptides corresponding to regions of the MS 11 sequence. 
Location of Strain-specific  Antigenic Determinants.  To locate more precisely the 
strain-specific epitopes  within the carboxyl terminal cyanogen bromide-gener- 
ated fragment of gonococcal pilin, four peptides were synthesized corresponding 
to residues 95-107,  107-121,  121-134,  and  135-151  (Table I). Peptides  121- 
134 and  135-151  compose a  disulfide loop, while 95-107  and  107-121  corre- 
spond  to  the  region  on  the  amino  terminal  side  of this  loop.  The  reduced 
suifhydryl of the  cysteine  at  either  the  carboxyl  or  amino  terminus  of each 
peptide was used to conjugate it to BSA using the hetero-bifunctional crosslinker 
SMCC.  Microtiter  plates  were  coated  with  the  BSA-peptide  conjugates  and 
antisera against MS 11  and R 10 pili were tested for their ability to bind to them. 
The homologous anti-MS11  serum  binds the two peptides corresponding to 
the disulfide loop, but not the peptides outside this region (Fig. 2A).  Anti-R10 
serum does not bind all four of these conjugates (Fig. 2 C). Additional proof that 
these peptides contain an epitope specific for MS11  pili is provided by binding 
experiments  with  antisera  against  the  carboxyi  terminal  cyanogen  bromide- 
generated fragments (CNBr-3)  or  MS11  and  R10.  Anti-MS11  CNBr-3  serum 
TABLE  I 
Amino Acid Sequences of the Eight Synthetic Oligopeptides and Their Corresponding Location 
in MS11 Pilin 
LP  A  YQDYTARAQVS  E  GC* 
21  35 -- 
EGQ  KS  AVTE  YGC 
41  50 -- 
TE  Y  Y  L  NHGKWP  E  NGC 
48  60 -- 
PP  S  DI  KGKYVKE  VE  VKGC 
69  84 -- 
CS  G  VNNE  I  KGKKL  S 
--  107 
95 
SL  W  ARRE  NGS  VKWF  C 
107  121 
CGQ  P  VT  R  TD  D  DTVA 
121  134 
DAK  DGKE  I  DTKHL  P  S 
135 
T  C 
151 
* Underlined residues do not exist in the primary structure of MS11 pilin. Additional glycine and 
cysteine residues were added  as spacers and as a  mode of attachment to carrier  molecules, 
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FIGURE 2.  Reaction  of anti-gonococcal  pili sera with peptide-BSA conjugates corresponding 
to regions of sequence variation between strains. Anti-MSl 1 pili (A), anti-MSl I CNBr-3 (B), 
anti-R10 pili (C), and anti-R10 CNBr-3 (D) antisera were assayed for their ability to bind 
peptides corresponding to residues 95-107 (0), 107-121 (O), 121-134 01), and 135-151 (D) 
of the MS11 pilin sequence. The enzyme-linked  immuno-binding assays were performed as 
described in Materials  and Methods. Each point represents the average of  three determinations. 
bound the two peptides comprising the disulfide loop even at dilutions as high 
as  1:6,400  (Fig.  2B),  whereas antiserum to the same fragment from R10 pilin 
binds very weakly and only at high serum concentrations (Fig. 2D). 
The observation that the two peptides that are bound both by polyclonal sera 
against whole MS 11 pili and against CNBr-3 are juxtaposed in sequence, creates 
the possibility that either there is a single epitope whose component amino acids 
are shared by the two peptides or that there are two independent epitopes, one 
within each peptide. This ambiguity was resolved easily by absorbing the MS 11 
pilus  antiserum  with  one  peptide  conjugate  and  then  studying the  absorbed 
serum's ability to bind the second peptide conjugate. If there is a  single shared 
determinant, then the absorption should reduce the amount of antibodies binding 
to the second peptide. If there are two epitopes, the absorption should not affect 
the serum's ability to bind the other conjugate. Absorption with peptide  121- 
134  has  no  affect on  the  serum's  ability  to  bind  135-151  and  reciprocally, 
absorption with peptide 135-151  does not affect the binding to 121-134 (Table 
II). Each peptide contains a strain-specific epitope. 
Identification  of a  Common  Determinant  in  Gonococcal  Pill  Even  though  the 
immunodominant epitopes  of gonococcal  pilin  are  strain  specific,  a  common 
determinant(s)  also  has  been  demonstrated  (Fig.  1)  to  exist  within  CNBr-2. 
Peptides  chosen  to  span  most  of this  region  of conserved  sequence  between 
MS 11 and R 10 pilin were synthesized as possible epitopes (Table I). Glycine and 214  ANTIGENIC  STRUCTURE  OF  GONOCOCCAL  PILl 
TABLE  II 
Reaction of Anti-MS11 Pili Sera with Peptides Corresponding to Residues 121-134 and 
135-151 Before and After Absorption* 
Dilution 
Polyclonal sera absorbed 
with Sepharose 
121-  135-151-  BSA 
134-BSA  BSA 
Polyclonal sera absorbed  Polyclonal sera absorbed 
with 121-134-BSA-Sepha-  with 135-151-BSA Sepha- 
rose  rose 
121-  135- 
135-  121-  134-  BSA  151-  BSA  151-BSA  134-BSA 
BSA  BSA 
@m  @m  @m  @m  @m  @m  ~m  @m  @m 
1:100  9,483  10,801  428  507  8,769  428  9,408  563  549 
1:500  2,229  2,856  145  193  2,062  I03  2,352  186  135 
1:1,000  1,245  1,450  89  150  1,101  78  1,496  110  75 
1:5,000  234  266  47  99  231  45  321  61  64 
1:10,000  152  249  37  69  155  26  167  78  88 
* Details of the absorption are described in Materials and Methods. Wells were coated with 10 ~g/ 
ml of either 121-134-BSA,  135-15 I-BSA, or BSA, treated with either absorbed or unabsorbed 
sera, washed, and then exposed to 50,000 cpm of "5I protein A. The values reported are averages 
of three separate determinations. 
cysteine were added to the carboxyl terminus of each peptide to allow them to 
be conjugated to BSA as previously described. Antisera against both MS11 and 
R10 pili and against  CNBr-2 of each pilin  were tested for their ability to bind 
these conjugates.  Anti-whole pili,  either  MS11  or R10, bound only the region 
corresponding to residues 48-60 (Fig.  3,A and C). As expected for a common, 
immunorecessive determinant,  both sera bind equally well, but significantly less 
than  the  sera  bind  the  strain-specific  epitopes.  Neither  sera  bound  peptides 
corresponding to residues 21-35, 41-50, or 69-84. 
A  different  binding  pattern  is  evident  when  antisera  against  the  cyanogen 
bromide-generated  fragment,  8-92,  of either  MS11  or  R10 is  used (Fig.  3,B 
and D). Anti-MS11  CNBr-2 binds the peptide corresponding to residues 69-84 
more  effectively than  48-60.  Anti-R10  CNBr-2  does  not  bind  48-60  at  all. 
Instead, this serum binds regions corresponding to residues 69-84 and 41-50. 
These experiments indicate that an epitope common to both R 10 and MS 11 
pili exists between residues 48-60 and that the immunogenicity of this region is 
determined  by  interactions  present  in  intact  pili  but  absent  from  CNBr-2. 
Another  common  determinant,  corresponding  to  residues  69-84,  evidently is 
exposed when CNBr-2 is used an an immunogen. 
A solid phase radio-binding assay was performed with the MS11 and R10 anti- 
whole  pili  sera  to  more  precisely  compare  the  relative  amount  of antibodies 
bound by the common and each of the strain-specific determinants.  Table III is 
a  compilation  of the  results of this  experiment.  At a  1 to  50  dilution  of anti- 
MS11 pili sera approximately three times as many antibodies are bound by each 
of the  strain-specific  epitopes  as  by  the  common  determinant.  Consequently 
<15%  of the  antigenicity  of whole  pili  resides  in  the  common  determinant, 
consistent with the data shown in Fig.  1. ROTHBARD  ET  AL.  215 
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FIGURE 3.  Reaction of anti-gonococcal pili sera with peptide-BSA conjugates corresponding 
to regions of conserved sequence between strains. Anti-MS11 pili (A), anti-MS11  CNBr-2 (B), 
anti-R10 pili (C),  and anti-R10 CNBr-2  (D)  antisera were  assayed for their ability to  bind 
peptides corresponding  to residues 21-35  (I),  41-50  (n), 48-60  (El), and 60-84  (O). The 
enzyme immuno-binding assays were performed as described in Materials and Methods. Each 
point represents the average of three determinations. 
TABLE  III 
Relative Binding of Polyclonal Rabbit Sera Against Intact MS11 Pill to Each of the Peptide-BSA 
Conjugates* 
BSA  21-35  41-50  48-60  09-84  95-107  107-121  121-134  135-151 
cp~  cpm  cpm  cpm  cp=  epm  cp,n  cpr~  cpm 
Ami-MSI 1  612+12  656:t:21  810:t:28  6,519±112  649±15  635±26  1,824±41  17,251±127  18,020±95 
1:50 
Relative  %  --  --  --  14.5  --  --  1.5  40.7  42.6 
* Wells were coated  with  10/~g/ml of the various  peptide-BSA  conjugates,  washed,  treated with a  1:50 dilution  of anti-MSl I  sera, washed, 
exposed to 50,000 cpm of ]SSl protein A. washed, and the wells were cut from the plate and counted. 
Discussion 
Defining the antigenic  structure of gonoccocal  pili is important for both the 
design of an efficacious vaccine and for providing molecular details that will lead 
to a general understanding of how pathogens create antigenic variation to avoid 
the host immune system. 
The  experiments  described  in  this paper  have  partially  defined  the natural 
epitopes of gonococcal  pili by using synthetic peptides corresponding to linear 
sequences of the protein. Two strain-specific determinants are located within the 
disulfide loop near the carboxyl terminus and a single epitope common to both 
strains R10 and MS11  is present between residues 48 and 60. We recognize that 
these areas might not constitute the complete antigenic structure of pili because P 
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if there are any determinants composed of nonlinear amino acids, created by the 
juxtaposition of residues due to either the folding of the pilin molecule or its 
polymerization,  they would  not  be  detected by these reagents.  However, an 
analysis of the regions containing the  linear  epitopes indicates  that  they can 
account for many of the interesting features of the antigenicity of gonococcal 
pill. 
The location of the three peptides containing the antigenic determinants (48- 
60,  121-134, and 135-151) as well as the five other areas synthesized within the 
MS11 pilin sequence are shown in Fig. 4. This figure also includes plots of the 
protein's hydrophilicity and its predicted secondary structure. Table IV compares 
the sequences of R 10 and MS 11 pilin in the eight regions synthesized as well as 
the quantitative predictions for/3-turns using the values compiled by Chou and 
Fasman (15). All known sequence variation between R 10 and MS 11 pilin occurs 
in the carboxyl terminal cyanogen bromide-generated fragment (CNBr-3, resi- 
dues 93-1,59) (7). The most striking feature of the variations in sequence between 
RI0  and  MS11  is  that  most  of the  differences occur  within  or  adjacent  to 
predicted ~/-turns and yet none of the substitutions affect the predicted secondary 
structure (Table IV). 
The initial choice of the peptides synthesized was based on several criteria, 
including  the  predicted  location  of /3-turns.  The  inherent  characteristics  of 
reverse turns makes them attractive both as immunogens within synthetic pep- 
tides and as possible antigenic determinants in globular proteins.  When a  syn- 
thetic peptide is used as an immunogen, the possible conformations that it can 
adopt  will  determine which clones in  the  B  cell repertoire are stimulated to 
produce antibody. Only if a  peptide adopts a  secondary structure identical to 
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FIGURE 4.  Location of the eight oligopeptides within the sequence of MSI 1 pilin, their 
predicted secondary structure (15), and their relative hydrophilicity. The relative hydrophil- 
icity of the protein was calculated by a  moving average over six residues using the values 
assigned by Levitt (16).  Positive values correspond to the hydrophilic regions. The shaded 
areas indicate regions of probable conformation. 
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TABLE  IV 
Comparison of MS11 and RIO Pilin Sequences in the Regions Synthesized and the Predicted 
Location of B-Turns 
Turn probabil- 
Sequences  ity* 
21  L  P  A  Y  Q  D  Y  T  A  R  A  Q  v  S  E  35  1.79x  10  -4 
41  E  G  Q  K  S  A  V  T  E  Y  50  0.76x  10  -4 
48  T  E  Y  Y  L  N  H  G  K  W  P  E  N  60  1.43x  10  -4  , 
1.62 X  10  -40 
S  D  I  K  G  K  Y  V  K  E  V  84  3.10x  10  -4 
MSI 1 
R10 
MSI 1 
R10 
MSI 1 
R10 
MSI 1 
R10 
MSI 1 
R10 
MS11 
R10 
MS1 1 
R10 
MS11 
R10 
69  P  P  E  VK 
[  ]' 
+ 
95  S  G  V  N  N  E  I  K  G  K  K  L  S  107  0.89X  10  -4 
-  N  -  -  K  -  -  -  D  0.84X  10  -4 
107  S  L  W  A  R  R  E  N  G  S  V  K  W  F  C  121  0.94X  10 -4 
K  -  -  A  0.86X  10 -4 
121 
+2  + 
C  G  Q  P  V  T  R  T  D  D  D  T  V  A  134  2.29X  10 -4 
A  -  K  -  N  R  T  2.75X  10 -4 
+  -2  + 
135  D  A  K  D  G  K  E  I  D  T  K  H  L  P  S  T  C  151  1.88X  10 -4 , 
1.81  X  10  -4 
V-  D  A  [  ] 
* Probability  of the  underlined  four  amino acids  to  be  present  in  a  reverse  turn  based  on  the 
algorithm derived by Chou and Fasman (15). Regions whose probability is greater than 0.7 x  10  -4 
are assigned as turns by this algorithm. Relative charge differences between the two sequences are 
shown above the indicated position of the MSI 1 peptide. 
* ---  indicates sequence identity between MS I 1 and R 10 pilin. 
g Two overlapping turns are predicted in this region, HGKW and WPEN. 
I [  ] indicates unsequenced regions of R10 pilin. 
that it assumes in the intact protein will  it both bind sera generated against the 
intact protein and elicit antibodies that cross-react with that protein.  Even if the 
antibody-combining site induces the peptide to adopt the correct conformation, 
a peptide having a higher probability to preexist in that conformation will have 
the lowest energy requirements  for binding.  Of the  three common  secondary 
structures present in proteins, B-pleated sheets, a-helices, and reverse or B-turns, 
we believe reverse  turns  have  the  highest  probability  of being  present  in  an 
isolated oligopeptide < 15 residues in length. Individual strands of a sheet require 
interactions  with  the  adjacent  strands  to  adopt  that  conformation  and  to  be 
subsequently stabilized  (17).  Helices can  form  in  an  isolated  peptide,  but  the 
peptide must be long enough to generate sufficient intrahelical  interactions  to 
stabilize the conformation (18). Further stabilization often results from a partic- 
ular  face of a  helix  interacting  with  adjacent  regions  of the  protein  (17).  In 218  ANTIGENIC STRUCTURE OF  GONOCOCCAL PILI 
contrast,  the forces involved in the formation  of a  reverse turn  are thought  to 
be  contained  within  the  primary  structure  of the  peptide  (19).  Therefore,  a 
peptide containing a  region with high turn probability will be more likely to be 
identical to the corresponding region in the intact protein than regions predicted 
to be sheets or helices. 
Turns also are present in immunologically interesting  regions in proteins.  A 
number of investigators have postulated that turns exist as a means of keeping a 
protein  globular  by reversing  the  direction  of a  sheet  or  helix  back  into  the 
center of a  protein,  which results in the turn  being present on the surface of a 
protein  (20-24).  Turns  also are  likely regions  for advantageous  mutations  to 
occur within  microbial  proteins  exposed to host immunity.  Unlike  sheets and 
helices, the amino acid side chains in turns interact with the solvent and not with 
other  regions  of the  protein.  Consequently,  as  long  as  the  substitution  of an 
amino acid maintains  the turn  there is no need to mutate a  second amino acid 
to conserve the correct tertiary structure of the protein, as might be the case if 
the mutation occurs in a helix or sheet. 
The  experiments  reported  in  this  paper  support  this  proposal.  Both of the 
peptides containing strain-specific determinants (121 - 134 and 1351-151 ) have a 
predicted turn  around  which the sequence variations are localized (Table IV). 
Each peptide also contains a turn within which there exists a position where one 
strain has a lysine, whereas the other contains an aspartic acid. Such a variation 
in sequence involving a double charge change could explain the total absence of 
cross-reactivity of the complementary antibody-combining sites. Another feature 
of the  strain-specific  determinants  is  that  they are  localized  within  a  disulfide 
loop, a region of the protein previously shown not to be involved in either pilin 
polymerization or receptor binding (8).  Single disulfide loops are also found in 
MoraxeUa bovis (G.  K.  Schoolnik,  unpublished observations), Pseudomonas aeru- 
ginosa (25), and common and  GaI-Gal binding Escherichia  coli  (26,  27) pili.  We 
believe that the location of the principal epitopes within the disulfide loop is part 
of a  sophisticated  molecular design  that  enables the  organism  to segregate  its 
principal antigenic determinants  in a region distinct from the residues involved 
in  receptor binding  and  subunit polymerization.  By using a  disulfide loop, we 
propose that the molecule has evolved a domain that (a) prominently orients the 
region  on  the  surface  of the  molecule,  perhaps  even  projecting out  from  the 
polymeric structure,  resulting in its increased antigenicity and immunogenicity; 
(b) allows amino acid substitutions, additions, and deletions within the antigenic 
determinants,  thereby maximizing antigenic variation,  without disrupting areas 
critical for the biological role of the protein; and (c) permits an antibody to bind 
pili and yet not interfere with gonococcal adhesion to the mucosal cell surface. 
The  highly  variable  antigenic  determinants  of influenza  virus  neuraminidase 
recently have been shown to be designed in a  similar fashion. They are located 
in/3-turns,  in a region distinct from the active site, which enables antibodies to 
bind to the epitopes without inhibiting the enzyme (28). 
In addition to making the regions within the disulfide loop immunodominant, 
the design of pilin also has resulted in the observed regions involved in receptor 
binding  being  immunorecessive.  Our  experiments  have  shown  that  the  small, 
cross-reactive antibody fraction of anti-pili sera is directed at an epitope located ROTHBARD ET  AL.  219 
between residues 48 and 60. The poor immunogenicity of this region compared 
with the strain-specific determinants  explains why pili from a single gonococcal 
strain are not suitable immunogens for use as a vaccine. In contrast,  the central 
cyanogen  bromide-generated  fragment  (CNBr-2,  residues  8-92)  elicits  anti- 
serum that cross-reacts well with heterologous gonococcal pili (8, Fig.  1). Exper- 
iments  in  this  paper indicate that  the principal  epitope of this fragment  is not 
between residues 48 and 60, but rather between residues 69 and 84, an area not 
recognized by sera against intact pili. The immunogenicity of the region corre- 
sponding to residues 69-84 apparently is greatly reduced in the intact protein. 
The  immunogenicity and  functional  properties of antibodies engendered  by 
the  synthetic peptides described  in  this  report and  to the  fragments  from  the 
conserved,  receptor-binding  region  of the  pilin  sequence  currently  are  being 
studied to identify suitable components for a vaccine. 
Summary 
The antigenic structure of gonococcal pilin, strain MS 11 (Tr), was investigated 
by assaying the binding of antisera engendered by intact pili from strains MS11 
and R 10 and their two major cyanogen bromide-generated fragments, CNBr-2 
(residues 9-92) and CNBr-2 (residues 93-159), to synthetic peptides correspond- 
ing to the amino acid sequence of MS11  pilin.  Four peptides were synthesized 
corresponding to regions of sequence variation  between MS11  and  R10 gono- 
coccal pilin. Antisera against the homologous pilus filament and against its CNBr- 
3 fragment bind peptides equivalent to residues  121-134 and  135-151, which 
comprise the  30 amino  acid disulfide  loop near  the  carboxy! terminus  of the 
protein.  Heterologous  pili  antisera  did  not  bind  these  peptides.  Absorption 
studies proved that  each peptide contained an independent,  strain-specific epi- 
tope. Synthetic peptides corresponding to regions of identical sequence between 
MSll  and  R10  pilin  were  used  in  similar  binding  experiments  to  localize  a 
weakly immunogenic, common determinant between residues 48 and 60. <15% 
of the  antibodies  raised  against  intact  pili  were directed  at  this  site.  Antisera 
raised against  MS11  or R10 CNBr-2 bind a  separate peptide,  residues 69-80. 
This region is immunogenic only as a fragment,  not in the intact pilus filament. 
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